I.-The holder of the systemic cancer drug treatment authorisation is organised in such a way that, in order to guarantee continuity of care for the patient, the following information can be communicated:
1° To the patient and to the patient’s treating doctor, information on how to deal with the most frequent foreseeable situations relating to the patient’s treatment requiring urgent medical advice;
2° To the patient or to the doctor who is to treat the patient, in an emergency if necessary, telephone contact details for the team responsible for the patient’s care protocol.
To this end, the organisation chosen by the authorisation holder may, depending on the severity and complexity of the systemic cancer drug treatment provided for the patient, provide for the doctor in the care team mentioned in articles D. 6124-134-1, D. 6124-134-2 or D. 6124-134-3 to be on call at nights and weekends.
II – The holder of the systemic cancer drug treatment modality organises a short circuit for unscheduled hospitalisation or emergency hospitalisation as referred to in II of article R. 6123-91-11, allowing complications to be managed by involving as soon as possible the care team that has mastered the patient’s systemic cancer drug treatment protocol.